| Year |
Title |
Altmetric |
| 2022
|
Peptides as Therapeutic Agents for Atherosclerosis.
Methods in Molecular Biology.
2419:89-110.
2022
|
|
| 2021
|
Nanodisc reconstitution of flavin mononucleotide binding domain of cytochrome-P450-reductase enables high-resolution NMR probing.
Chemical Communications.
57:4819-4822.
2021
|
|
| 2021
|
Apolipoprotein mimetic peptides: An emerging therapy against diabetic inflammation and dyslipidemia.
Biomolecules.
11.
2021
|
|
| 2020
|
The apolipoprotein a-i mimetic l-4f attenuates monocyte activation and adverse cardiac remodeling after myocardial infarction.
International Journal of Molecular Sciences.
21.
2020
|
|
| 2020
|
Expression, purification, and functional reconstitution of 19F-labeled cytochrome b5 in peptide nanodiscs for NMR studies
2020
|
|
| 2020
|
Structural Interaction of Apolipoprotein A-I Mimetic Peptide with Amyloid-β Generates Toxic Hetero-oligomers.
Journal of Molecular Biology.
432:1020-1034.
2020
|
|
| 2019
|
Apolipoprotein A-I mimetics mitigate intestinal inflammation in a COX2-dependent inflammatory disease model.
Journal of Clinical Investigation.
129:3670-3685.
2019
|
|
| 2019
|
Corrigendum to “Solid-state NMR structural investigations of peptide-based nanodiscs and of transmembrane helices in bicellar arrangements” [Chem. Phys. Lipids 219 (2019) 58–71] (Chemistry and Physics of Lipids (2019) 219 (58–71), (S0009308418302056), (10.1016/j.chemphyslip.2019.01.012)).
Chemistry and Physics of Lipids.
221:219.
2019
|
|
| 2019
|
Lipoprotein modulation of proteinuric renal injury.
Laboratory Investigation.
99:1107-1116.
2019
|
|
| 2019
|
Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein.
Molecular and Cellular Proteomics.
18:854-864.
2019
|
|
| 2019
|
Apolipoprotein A1 Forms 5/5 and 5/4 Antiparallel Dimers in Human High-density Lipoprotein..
Molecular and Cellular Proteomics.
18:854-864.
2019
|
|
| 2019
|
High-resolution structural studies elucidate antiatherogenic and anti-inflammatory properties of peptides designed to mimic amphipathic α-helical domains of apolipoprotein A-I
2019
|
|
| 2019
|
Solid-state NMR structural investigations of peptide-based nanodiscs and of transmembrane helices in bicellar arrangements.
Chemistry and Physics of Lipids.
219:58-71.
2019
|
|
| 2019
|
The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.
Chemistry and Physics of Lipids.
219:28-35.
2019
|
|
| 2019
|
Probing membrane enhanced protein-protein interactions in a minimal redox complex of cytochrome-P450 and P450-reductase.
Chemical Communications.
55:5777-5780.
2019
|
|
| 2019
|
Probing protein-protein and protein-substrate interactions in the dynamic membrane-associated ternary complex of cytochromes P450,: B 5, and reductase.
Chemical Communications.
55:13422-13425.
2019
|
|
| 2018
|
Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation.
Journal of Molecular Biology.
430:4230-4244.
2018
|
|
| 2018
|
Supramolecular Organization of Apolipoprotein-A-I-Derived Peptides within Disc-like Arrangements.
Biophysical Journal.
115:467-477.
2018
|
|
| 2018
|
Retraction: Crystal structure of human apolipoprotein a-i: Insights into its protective effect against cardiovascular diseases (Proc Natl Acad Sci USA (2006) 103 (2126–2131) DOI: 10.1073/pnas.0506877103)
2018
|
|
| 2018
|
A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs.
Angewandte Chemie International Edition.
57:8458-8462.
2018
|
|
| 2018
|
Real-Time Monitoring of Lipid Exchange via Fusion of Peptide Based Lipid-Nanodiscs.
Chemistry of Materials.
30:3204-3207.
2018
|
|
| 2018
|
Cytochrome-P450-Induced Ordering of Microsomal Membranes Modulates Affinity for Drugs.
Angewandte Chemie International Edition.
57:3391-3395.
2018
|
|
| 2018
|
ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch’s Membrane and Causes Its Structural Remodeling.
Current Eye Research.
43:135-146.
2018
|
|
| 2018
|
Lipid-exchange in nanodiscs discloses membrane boundaries of cytochrome-P450 reductase.
Chemical Communications.
54:6336-6339.
2018
|
|
| 2018
|
Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Journal of Lipid Research.
59:2075-2083.
2018
|
|
| 2018
|
The apolipoprotein e mimetic peptide AEM-2 attenuates mitochondrial injury and apoptosis in human THP-1 macrophages.
Current topics in peptide & protein research.
19:15-25.
2018
|
|
| 2017
|
Kinetic and Structural Characterization of the Effects of Membrane on the Complex of Cytochrome b 5 and Cytochrome c.
Scientific Reports.
7.
2017
|
|
| 2017
|
Cholesterol reduction and macrophage function: Role of paraoxonases.
Current Opinion in Lipidology.
28:397-402.
2017
|
|
| 2017
|
Membrane environment drives cytochrome P450's spin transition and its interaction with cytochrome: B 5.
Chemical Communications.
53:12798-12801.
2017
|
|
| 2016
|
Apolipoprotein mimetic peptides as modulators of lipoprotein function
2016
|
|
| 2016
|
High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms.
Chemistry and Physics of Lipids.
199:161-169.
2016
|
|
| 2016
|
Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.
Journal of Lipid Research.
57:1175-1193.
2016
|
|
| 2015
|
Recent developments in modulating atherogenic lipoproteins.
Current Opinion in Lipidology.
26:369-375.
2015
|
|
| 2015
|
Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer
2015
|
|
| 2015
|
Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.
Biochemical Journal.
467:517-527.
2015
|
|
| 2015
|
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
Journal of Lipid Research.
56:871-887.
2015
|
|
| 2015
|
Novel method for reducing plasma cholesterol: A ligand replacement therapy.
Clinical Lipidology.
10:83-90.
2015
|
|
| 2014
|
Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
Innate Immunity.
20:867-880.
2014
|
|
| 2014
|
Quantification of HDL particle concentration by calibrated ion mobility analysis
2014
|
|
| 2014
|
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review.
Journal of Lipid Research.
55:2007-2021.
2014
|
|
| 2014
|
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils.
Inflammation.
37:1401-1412.
2014
|
|
| 2014
|
Apolipoprotein A-I mimetics.
Current Opinion in Lipidology.
25:304-308.
2014
|
|
| 2014
|
Searching for a successful HDL-based treatment strategy
2014
|
|
| 2014
|
Searching for a successful HDL-based treatment strategy.
2014
|
|
| 2013
|
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid.
Journal of Lipid Research.
54:3403-3418.
2013
|
|
| 2013
|
Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.
Biochemical and Biophysical Research Communications.
436:705-710.
2013
|
|
| 2013
|
Recent progress in the development of apoA-I and apoE mimetic therapies.
Clinical Lipidology.
8:265-268.
2013
|
|
| 2013
|
Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis.
PLoS One.
8.
2013
|
|
| 2013
|
A novel approach to oral apoA-I mimetic therapy.
Journal of Lipid Research.
54:995-1010.
2013
|
|
| 2013
|
Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice.
Atherosclerosis.
227:58-64.
2013
|
|
| 2013
|
Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.
Biochemical and Biophysical Research Communications.
430:975-980.
2013
|
|
| 2013
|
In vivo and in vitro effects of an apolipoprotein E mimetic peptide on amyloid-β pathology.
Journal of Alzheimer's Disease.
36:335-347.
2013
|
|
| 2012
|
Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F
2012
|
|
| 2012
|
Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Atherosclerosis.
224:326-331.
2012
|
|
| 2012
|
Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F.
Journal of Lipid Research.
53:1576-1587.
2012
|
|
| 2012
|
Sidedness of interfacial arginine residues and anti-atherogenicity of apolipoprotein A-I mimetic peptides.
Journal of Lipid Research.
53:849-858.
2012
|
|
| 2012
|
D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD.
International Journal of Cancer.
130:1071-1081.
2012
|
|
| 2012
|
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice.
Journal of Lipid Research.
53:437-445.
2012
|
|
| 2011
|
HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats..
Journal of Clinical and Experimental Cardiology.
2.
2011
|
|
| 2011
|
Apolipoprotein E mimetics and cholesterol-lowering properties.
American Journal of Cardiovascular Drugs.
11:371-381.
2011
|
|
| 2011
|
Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.
Journal of Lipid Research.
52:1795-1809.
2011
|
|
| 2011
|
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally.
Journal of Lipid Research.
52:1200-1210.
2011
|
|
| 2011
|
L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways
2011
|
|
| 2011
|
Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function.
Journal of Lipid Research.
52:435-450.
2011
|
|
| 2011
|
Structure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G* apolipoprotein J peptide using solution NMR
2011
|
|
| 2010
|
ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
Advances in Experimental Medicine and Biology.
660:1-4.
2010
|
|
| 2010
|
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice.
Journal of Lipid Research.
51:3491-3499.
2010
|
|
| 2010
|
Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
Atherosclerosis.
213:449-457.
2010
|
|
| 2010
|
L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice.
Drug Metabolism Letters.
4:139-148.
2010
|
|
| 2010
|
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer
2010
|
|
| 2010
|
The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.
Journal of Lipid Research.
51:2695-2705.
2010
|
|
| 2010
|
Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.
Pediatric Research.
68:128-133.
2010
|
|
| 2010
|
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
2010
|
|
| 2010
|
Structure and function of HDL mimetics
2010
|
|
| 2010
|
Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2.
Atherosclerosis.
208:134-141.
2010
|
|
| 2010
|
Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.
Pediatric Research.
68:128-133.
2010
|
|
| 2010
|
L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation
2010
|
|
| 2010
|
Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine.
Laboratory Investigation.
90:128-139.
2010
|
|
| 2009
|
HDL as a biomarker, potential therapeutic target, and therapy.
Diabetes.
58:2711-2717.
2009
|
|
| 2009
|
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Journal of Lipid Research.
50:1538-1547.
2009
|
|
| 2009
|
Anti-inflammatory peptides grab on to the whiskers of atherogenic oxidized lipids
2009
|
|
| 2009
|
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats
2009
|
|
| 2009
|
Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease.
Neurobiology of Disease.
34:525-534.
2009
|
|
| 2009
|
The role of dysfunctional HDL in atherosclerosis.
Journal of Lipid Research.
50.
2009
|
|
| 2009
|
Apolipoprotein A-I mimetic peptides..
Current Atherosclerosis Reports.
11:52-57.
2009
|
|
| 2009
|
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.)..
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry.
6:122-130.
2009
|
|
| 2008
|
Effect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: High resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex.
Journal of Biological Chemistry.
283:34393-34402.
2008
|
|
| 2008
|
Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
Journal of Lipid Research.
49:2302-2311.
2008
|
|
| 2008
|
HDL therapy for cardiovascular diseases: The road to HDL mimetics.
Current Atherosclerosis Reports.
10:405-412.
2008
|
|
| 2008
|
Multiple indications for anti-inflammatory apolipoprotein mimetic peptides
2008
|
|
| 2008
|
Apo A-1 mimetic peptides as atheroprotective agents in murine models.
Current Drug Targets.
9:204-209.
2008
|
|
| 2008
|
The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis.
Trends in Cardiovascular Medicine.
18:61-66.
2008
|
|
| 2008
|
D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet.
Journal of Lipid Research.
49:192-205.
2008
|
|
| 2007
|
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits.
Journal of Lipid Research.
48:2344-2353.
2007
|
|
| 2007
|
High-density lipoprotein: Antioxidant and anti-inflammatory properties.
Current Atherosclerosis Reports.
9:244-248.
2007
|
|
| 2007
|
Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides.
Journal of Lipid Research.
48:1915-1923.
2007
|
|
| 2007
|
Peptide mimetics of apolipoproteins improve HDL function.
Journal of Clinical Lipidology.
1:142-147.
2007
|
|
| 2007
|
Apolipoprotein A-I Mimetic Peptides and Their Role in Atherosclerosis Prevention.
Peptide Science -Symposium-.
2006:225-226.
2007
|
|
| 2007
|
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.
Journal of Biological Chemistry.
282:1980-1988.
2007
|
|
| 2006
|
Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention
2006
|
|
| 2006
|
D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.
Journal of Lipid Research.
47:2148-2160.
2006
|
|
| 2006
|
Mechanisms of disease: Proatherogenic HDL - An evolving field.
Nature Reviews Endocrinology.
2:504-511.
2006
|
|
| 2006
|
Atherosclerosis and vascular disease: Effects of peptide mimetics of apolilpoproteins.
Current Pharmaceutical Biotechnology.
7:235-240.
2006
|
|
| 2006
|
Potential clinical utility of high-density lipoprotein-mimetic peptides.
Current Opinion in Lipidology.
17:440-444.
2006
|
|
| 2006
|
Synthetic peptides: Managing lipid disorders.
Current Opinion in Lipidology.
17:233-237.
2006
|
|
| 2006
|
Association of a model class A (apolipoprotein) amphipathic α helical peptide with lipid: High resolution NMR studies of peptide-lipid discoidal complexes.
Journal of Biological Chemistry.
281:6511-6519.
2006
|
|
| 2006
|
Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases
2006
|
|
| 2006
|
Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1.
Journal of Lipid Research.
47:107-114.
2006
|
|
| 2006
|
Oral amphipathic peptides as therapeutic agents.
Expert Opinion on Investigational Drugs.
15:13-21.
2006
|
|
| 2005
|
An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I.
Circulation Research.
97:1085-1086.
2005
|
|
| 2005
|
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Circulation Research.
97:524-532.
2005
|
|
| 2005
|
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
2005
|
|
| 2005
|
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide.
Circulation Research.
97:236-243.
2005
|
|
| 2005
|
ApoA-I mimetic peptides as anti-inflammatory agents.
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry.
5:335-338.
2005
|
|
| 2005
|
Apolipoprotein A-I mimetic peptides - ATVB in focus
2005
|
|
| 2005
|
D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice
2005
|
|
| 2005
|
Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits.
Circulation.
111:3112-3118.
2005
|
|
| 2005
|
The role of high-density lipoprotein in inflammation.
Trends in Cardiovascular Medicine.
15:158-161.
2005
|
|
| 2004
|
Two homologous apolipoprotein AI mimetic peptides: Relationship between membrane interactions and biological activity.
Journal of Biological Chemistry.
279:51404-51414.
2004
|
|
| 2004
|
Human apolipoprotein A-I and A-I mimetic peptides: Potential for atherosclerosis reversal.
Current Opinion in Lipidology.
15:645-649.
2004
|
|
| 2004
|
Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids.
Journal of Biological Chemistry.
279:49931-49939.
2004
|
|
| 2004
|
D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
Circulation.
110:3252-3258.
2004
|
|
| 2004
|
Double belt structure of discoidal high density lipoproteins: Molecular basis for size heterogeneity.
Journal of Molecular Biology.
343:1293-1311.
2004
|
|
| 2004
|
Antiinflammatory properties of HDL.
Circulation Research.
95:764-772.
2004
|
|
| 2004
|
Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells.
Journal of Lipid Research.
45:1919-1928.
2004
|
|
| 2004
|
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport
2004
|
|
| 2004
|
Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux.
Journal of Biological Chemistry.
279:25966-25977.
2004
|
|
| 2004
|
Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity.
Journal of Biological Chemistry.
279:26509-26517.
2004
|
|
| 2004
|
An Apolipoprotein AI Mimetic Peptide: Membrane Interactions and the Role of Cholesterol.
Biochemistry.
43:5073-5083.
2004
|
|
| 2004
|
Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice..
Circulation.
109:3215-3220.
2004
|
|
| 2003
|
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis
2003
|
|
| 2003
|
A quantitative analysis of apolipoprotein binding to SR-BI: Multiple binding sites for lipid-free and lipid-associated apolipoproteins.
Journal of Lipid Research.
44:1132-1142.
2003
|
|
| 2003
|
Effect of an arginine-rich amphipathic helical peptide on plasma cholesterol in dyslipidemic mice.
Atherosclerosis.
168:229-237.
2003
|
|
| 2002
|
Influence of apoE domain structure and polymorphism on the kinetics of phospholipid vesicle solubilization.
Journal of Lipid Research.
43:1688-1700.
2002
|
|
| 2002
|
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Circulation.
106:1127-1132.
2002
|
|
| 2002
|
Sustained-delivery of an apolipoproteinE-peptidomimetic using multivesicular liposomes lowers serum cholesterol levels.
Journal of Controlled Release.
79:207-218.
2002
|
|
| 2002
|
Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Circulation.
105:290-292.
2002
|
|
| 2001
|
Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
Journal of Lipid Research.
42:1096-1104.
2001
|
|
| 2001
|
Toward the design of peptide mimics of antiatherogenic apolipoproteins A-I and E.
Current Science.
81:53-65.
2001
|
|
| 2001
|
Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
Journal of Lipid Research.
42:959-966.
2001
|
|
| 2001
|
NMR conformational analysis of cis and trans proline isomers in the neutrophil chemoattractant, N-acetyl-proline-glycine-proline.
Biospectroscopy.
58:548-561.
2001
|
|
| 2001
|
A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis.
Journal of Lipid Research.
42:545-552.
2001
|
|
| 2001
|
Solution NMR structure of a model class A (apolipoprotein) amphipathic α helical peptide.
Regulatory Peptides.
22:567-573.
2001
|
|
| 2001
|
Structural models of human apolipoprotein A-I: A critical analysis and review
2001
|
|
| 2001
|
Effect of magainin, class L, and class A amphipathic peptides on fatty acid spin labels in lipid bilayers
2001
|
|
| 2001
|
Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: Nucleation model of defect formation.
Biophysical Journal.
81:949-959.
2001
|
|
| 2000
|
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Step 1.
Journal of Lipid Research.
41:1481-1494.
2000
|
|
| 2000
|
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: Steps 2 and 3.
Journal of Lipid Research.
41:1495-1508.
2000
|
|
| 2000
|
Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic α-helix as a recognition motif.
Journal of Biological Chemistry.
275:18897-18904.
2000
|
|
| 2000
|
A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples.
Journal of Lipid Research.
41:1020-1026.
2000
|
|
| 2000
|
Structure and function of apolipoprotein A-I and high-density lipoprotein.
Current Opinion in Lipidology.
11:105-115.
2000
|
|
| 2000
|
The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts.
Biochemistry.
39:213-220.
2000
|
|
| 1999
|
Pre-beta-HDL stimulates placental lactogen release from human trophoblast cells..
American Journal of Physiology.
276:E384-E389.
1999
|
|
| 1999
|
Apolipoprotein-mediated plasma membrane microsolubilization: Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid.
Journal of Biological Chemistry.
274:2021-2028.
1999
|
|
| 1999
|
Bioactivity of peptide analogs of the neutrophil chemoattractant, N- acetyl-proline-glycine-proline
1999
|
|
| 1999
|
Pre-β-HDL stimulates placental lactogen release from human trophoblast cells
1999
|
|
| 1998
|
The lipid-free structure of apolipoprotein A-I: Effects of amino- terminal deletions.
Biochemistry.
37:11714-11725.
1998
|
|
| 1998
|
Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic α-helixes.
Biochemistry.
37:10313-10324.
1998
|
|
| 1998
|
Studies of kinetics and equilibrium membrane binding of class A and class L model amphipathic peptides
1998
|
|
| 1997
|
Effect of vesicle size on their interaction with class A amphipathic helical peptides.
Journal of Lipid Research.
38:2147-2154.
1997
|
|
| 1997
|
Interaction of class A amphipathic helical peptides with phospholipid unilamellar vesicles.
Journal of Lipid Research.
38:2134-2146.
1997
|
|
| 1997
|
Role of lipids in the permeabilization of membranes by class L amphipathic helical peptides.
Biochemistry.
36:9237-9245.
1997
|
|
| 1997
|
Truncation of the amine terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation.
Biochemistry.
36:288-300.
1997
|
|
| 1996
|
Human placental tissue expresses a novel 22.7 kDa apolipoprotein A-I-like protein.
Biochemistry.
35:7580-7585.
1996
|
|
| 1996
|
Probing structure and function of VLDL by synthetic amphipathic helical peptides.
Journal of Lipid Research.
37:1099-1112.
1996
|
|
| 1996
|
Chromatographic methods for quantitation of apolipoprotein A-I.
Methods in Enzymology.
263:267-282.
1996
|
|
| 1996
|
Only the two end helixes of eight tandem amphipathic helical domains of human Apo A-I have significant lipid affinity: Implications for HDL assembly
1996
|
|
| 1995
|
Molecular Basis for Prokaryotic Specificity of Magainin-Induced Lysis.
Biochemistry.
34:4393-4401.
1995
|
|
| 1995
|
Structural models of human apolipoprotein A-I
1995
|
|
| 1995
|
Effect of the arrangement of tandem repeating units of class A amphipathic α-helixes on lipid interaction.
Journal of Biological Chemistry.
270:1602-1611.
1995
|
|
| 1995
|
Effect of the cholesterol content of reconstituted LpA-I on lecithin:cholesterol acyltransferase activity.
Journal of Biological Chemistry.
270:5151-5157.
1995
|
|
| 1995
|
Efflux of Cellular Cholesterol and Phospholipid to Lipid-Free Apolipoproteins and Class A Amphipathic Peptides.
Biochemistry.
34:7955-7965.
1995
|
|
| 1995
|
Localization of a Domain in Apolipoprotein E with both Cytostatic and Cytotoxic Activity.
Biochemistry.
34:11142-11151.
1995
|
|
| 1995
|
Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides.
Biospectroscopy.
37:319-338.
1995
|
|
| 1995
|
Microenvironments of Basic Amino Acids in Amphipathic a-Helices Bound to Phospholipid: 13C NMR Studies Using Selectively Labeled Peptides.
Biochemistry.
34:9219-9226.
1995
|
|
| 1994
|
Binding of apolipoprotein A-I model peptides to lipid bilayers. Measurement of binding isotherms and peptide-lipid headgroup interactions.
Journal of Biological Chemistry.
269:23904-23910.
1994
|
|
| 1994
|
The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
Journal of Biological Chemistry.
269:22975-22982.
1994
|
|
| 1994
|
ApoB-100 has a pentapartite structure composed of three amphipathic α-helical domains alternating with two amphipathic β-strand domains: Detection by the computer program LOCATE
1994
|
|
| 1994
|
HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity
1994
|
|
| 1994
|
Interactions of synthetic peptide analogs of the class A amphipathic helix with lipids. Evidence for the snorkel hypothesis.
Journal of Biological Chemistry.
269:7185-7191.
1994
|
|
| 1994
|
Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride- rich lipoproteins
1994
|
|
| 1994
|
Mixing rates can markedly affect the kinetics of peptide-induced leakage from liposomes.
IUBMB Life.
33:1073-1079.
1994
|
|
| 1994
|
Pathogenesis of atherosclerosis.
Current Opinion in Cardiology.
9:404-410.
1994
|
|
| 1994
|
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
Journal of Clinical Investigation.
94:1698-1705.
1994
|
|
| 1994
|
The amphipathic α helix: A multifunctional structural motif in plasma apolipoproteins.
Advances in protein chemistry and structural biology.
45:303-369.
1994
|
|
| 1993
|
An insulin receptor peptide (1135-1156) stimulates guanosine 5'[γ-thio]triphosphate binding to the 67 kDa G-protein associated with the insulin receptor.
Biochemical Journal.
294:19-24.
1993
|
|
| 1993
|
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins.
Journal of Biological Chemistry.
268:22895-22899.
1993
|
|
| 1993
|
Effect of end group blockage on the properties of a class A amphipathic helical peptide
1993
|
|
| 1993
|
Reciprocal effects of apolipoprotein and lytic peptide analogs on membranes. Cross-sectional molecular shapes of amphipathic α helixes control membrane stability.
Journal of Biological Chemistry.
268:22112-22118.
1993
|
|
| 1993
|
Solution structure of the v3 loop of a thailand hiv isolate.
Journal of Biomolecular Structure and Dynamics.
11:345-366.
1993
|
|
| 1992
|
Computer programs to identify and classify amphipathic α helical domains.
Journal of Lipid Research.
33:287-296.
1992
|
|
| 1992
|
Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
Journal of Biological Chemistry.
267:7121-7127.
1992
|
|
| 1992
|
The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function.
Journal of Lipid Research.
33:141-166.
1992
|
|
| 1992
|
Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats: Correlation with physical properties
1992
|
|
| 1991
|
Apolipoprotein A-I decreases neutrophil degranulation and superoxide production.
Journal of Lipid Research.
32:1911-1918.
1991
|
|
| 1991
|
Role of amphipathic helixes in HDL structure/function.
Advances in Experimental Medicine and Biology.
285:131-140.
1991
|
|
| 1991
|
Erratum: Amphipathic helix motif: Classes and properties (Proteins (1990) 8 (103-117))
1991
|
|
| 1991
|
Inhibition of virus‐induced cell fusion by apolipoprotein A‐I and its amphipathic peptide analogs.
Journal of Cellular Biochemistry.
45:224-237.
1991
|
|
| 1990
|
Thermodynamics of the binding of human apolipoprotein A-I to dimyristoylphosphatidylglycerol.
Journal of Biological Chemistry.
265:20829-20832.
1990
|
|
| 1990
|
Nuclear magnetic resonance investigation of the interaction with phospholipid of an amphipathic α-helix-forming peptide of the apolipoprotein class.
Journal of Biological Chemistry.
265:12217-12223.
1990
|
|
| 1990
|
Interactions of Serum Proteins with Small Unilamellar Liposomes Composed of Dioleoylphosphatidylethanolamine and Oleic Acid: High-Density Lipoprotein, Apolipoprotein A1, and Amphipathic Peptides Stabilize Liposomes.
Biochemistry.
29:3637-3643.
1990
|
|
| 1990
|
Amphipathic helix motif: Classes and properties
1990
|
|
| 1990
|
Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogs.
Virology.
176:48-57.
1990
|
|
| 1990
|
Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.
Journal of Clinical Investigation.
86:1142-1150.
1990
|
|
| 1990
|
Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
Arteriosclerosis (Dallas, Tex.).
10:95-105.
1990
|
|
| 1989
|
Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: Use of this peptide sequence in the synthesis of biologically active peptides
1989
|
|
| 1989
|
Properties of lipid complexes with amphipathic helix-forming peptides. Role of distribution of peptide charges.
Journal of Biological Chemistry.
264:4628-4635.
1989
|
|
| 1989
|
Synthetic amphipathic peptides resembling apolipoproteins stimulate the release of human placental lactogen.
Journal of Biological Chemistry.
264:9215-9219.
1989
|
|
| 1988
|
Effect of oxidation on the properties of apolipoproteins A-1 and A-II.
Journal of Lipid Research.
29:309-318.
1988
|
|
| 1987
|
Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I..
Journal of Biological Chemistry.
262:12189-12195.
1987
|
|
| 1987
|
Synthesis of 3-O-β-d-xylopyranosyl-l-serine (xylosylserine) and O-β-d-galactopyranosyl-(1-4)-O-β-d-xylopyranosyl-l-serine (galactosylxylosylserine) and use of the synthetic products for detection of galactosyltransferase I activity in rat liver.
Glycoconjugate Journal.
4:255-266.
1987
|
|
| 1987
|
Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation..
Journal of Biological Chemistry.
262:9389-9396.
1987
|
|
| 1987
|
Structural and biological studies on synthetic peptide analogues of a low-affinity calcium-binding site of skeletal troponin C
1987
|
|
| 1987
|
Characterization of high density lipoprotein subspecies: Structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography.
Journal of Lipid Research.
28:913-929.
1987
|
|
| 1986
|
[36] Synthetic Peptide Analogs of Apolipoproteins.
Methods in Enzymology.
128:627-647.
1986
|
|
| 1985
|
Studies of synthetic peptide analogs of the amphiphatic helix. Structure of complexes with dimyristoyl phosphatidylcholine.
Journal of Biological Chemistry.
260:10248-10255.
1985
|
|
| 1982
|
Resolution of α-methyl amino esters by chymotrypsin
1982
|
|
| 1980
|
Use of immobilized carboxypeptidase Y (I-CPY) as a catalyst for deblocking in peptide synthesis.
Biochimie.
62:537-541.
1980
|
|
| 1979
|
Removal of Benzyl-Type Protecting Groups from Peptides by Catalytic Transfer Hydrogenation with Formic Acid.
Journal of Organic Chemistry.
44:3442-3444.
1979
|
|
| 1977
|
Transfer hydrogenation; a convenient method for removal of some commonly used protecting groups in peptide synthesis.
Organic and Biomolecular Chemistry.
490-491.
1977
|
|
| 1974
|
FIBRINOPEPTIDES. III. SYNTHESIS OF THE PROTECTED NONAPEPTIDE SEQUENCE OF FIBRINOPEPTIDE‐B OF GREEN MONKEY.
Chemical Biology and Drug Design.
6:51-54.
1974
|
|
